1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:The aneurysm occlusion status during the follow-upa
Group A (%) Group B (%) P Value Initial RR I 24 (66.7) 23 (76.7) .69 RR II 11 (30.6) 6 (20) RR III 1 (2.8) 1 (3.3)b ≤4 mo RR I 18 (72) 17 (89.5) .08 RR II 7 (28) 1 (5.3) RR III 1 (5.3) 5–12 mo RR I 28 (84.8) 26 (92.9) .43 RR II 5 (15.2) 2 (7.1) RR III ≥12 mo RR I 26 (83.9) 23 (95.8) .21 RR II 5 (16.1) 1 (4.2) RR III Final follow-up RR I 31 (86.1) 28 (93.3) .14 RR II 5 (13.9) 1 (3.3) RR III 1 (3.3)